Yan Xu
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 140
- Cancer Immunotherapy and Biomarkers 50
- Lung Cancer Research Studies 44
-
- Lung Cancer Treatments and Mutations 73
- Lung Cancer Diagnosis and Treatment 30
- Co-authors
- Jun ChenQinghua ZhouHongyu LiuMengzhao WangMinjiang ChenJing ZhaoDorothy BeckettWei Zhong
- Journals
- Journal of Clinical Oncology (15 papers)Blood (11 papers)Frontiers in Immunology (9 papers)Frontiers in Oncology (7 papers)Medicine (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yan Xu
391 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.8k
- Cancer Research 742
- Immunology 553
- Molecular Biology 1.7k
Countries citing papers authored by Yan Xu
This map shows the geographic impact of Yan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xu more than expected).
Fields of papers citing papers by Yan Xu
This network shows the impact of papers produced by Yan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xu. The network helps show where Yan Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 7 | |
| 12 | 2019 | 12 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 11 | |
| 15 | Serum Exosomal Long Noncoding RNA pcsk2-2:1 As A Potential Novel Diagnostic Biomarker For Gastric Cancer | 2019 | 1 |
| 16 | 2017 | 59 | |
| 17 | 2017 | 45 | |
| 18 | 2017 | 24 | |
| 19 | 2014 | 4 | |
| 20 | 2013 | 1 |
About Yan Xu
Yan Xu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Hematology, having authored 432 papers that have together received 5.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (73 papers), Cancer Immunotherapy and Biomarkers (50 papers), Lung Cancer Research Studies (44 papers), Lung Cancer Diagnosis and Treatment (30 papers), Cancer Genomics and Diagnostics (18 papers), Multiple Myeloma Research and Treatments (14 papers), Immunotherapy and Immune Responses (14 papers) and Radiomics and Machine Learning in Medical Imaging (13 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.8k citations), Cancer Research (742 citations), Immunology (553 citations) and Molecular Biology (1.7k citations). Yan Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jun Chen, Qinghua Zhou, Hongyu Liu, Mengzhao Wang, Minjiang Chen, Jing Zhao, Dorothy Beckett, Wei Zhong, Jianfeng Lin and Jiawei Zhou. Their work appears in journals such as Journal of Clinical Oncology, Blood, Frontiers in Immunology, Frontiers in Oncology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.